The DSM-5 definition of bipolar disorder elevates increased activity or energy as a cardinal symptom (alongside mood changes) for mania and hypomania ('hypo/mania'). The ICD-10 likewise requires increases in activity and energy (alongside mood) for hypo/mania, as well as decreases for bipolar depression. Using bipolar disorder as an example, we propose that, when diagnostic criteria are revised, instruments used to measure clinical course and treatment response may need revisiting. Here, we highlight that the 'gold-standard' symptom rating scales for hypo/mania and depression were developed in an era when abnormalities of mood were viewed as the cardinal symptom of bipolar disorder. We contend that archetypal measures fail to give proportionate weighting to activity or energy, undermining their utility in monitoring bipolar disorder and treatment response in clinical and research practice.
As with other psychiatric conditions, the definition of bipolar disorder appears in two (related but different) types of artefactdiagnostic criteria aimed at optimising binary decisions about the presence of disorder in a given case, and symptom rating scales designed to quantify the disorder's severity at a point in time. We contend here that changes to diagnostic criteria have led to a substantive misalignment with major bipolar disorder rating scales. Recognition of activation as a central component of bipolar disorder, and consequent changes to diagnostic criteria, mean that long-established scales may no longer reflect current understanding and diagnosis of the disorder.
From manic depressive insanity to bipolar disorders (and back again?)
Early descriptions of manic depressive insanity (MDI) identified that the core, shared dimensions of acute illness episodes reflected disturbances of mood, cognition and motor activity. 1 Although Kraepelin 1 did not give primacy to any specific dimension, others suggested that change in psychomotor activity rather than mood was the most striking and consistent feature of MDI. 2 Over the next half century, however, descriptive attention shifted towards abnormalities of mood. Specifically, MDI was characterised in terms of two mood states, representing opposite poles of an implied pathological axis, and by the 1980s, the term 'bipolar disorder' replaced MDI. DSM-III and later revisions (DSM-III-R, DSM-IV, DSM-IV-TR) identified mood change as the defining feature (A criterion) of the depressive and hypo/manic mood episodes making up the bipolar disorder diagnosis, with psychomotor disturbances among the seven B criteria (i.e. not essential for the diagnosis). Similar approaches were used in ICD-8 and ICD-9 to diagnose bipolar disorder.
Views of the optimal criteria for diagnosing bipolar disorder and its subtypes continued to evolve and by the turn of the century, the ICD-10 described bipolar disorder as being characterised by repeated episodes in which the patient's mood and activity levels are significantly disturbed. 3 The ICD-10 description of bipolar disorder notes that individuals will show increased mood, energy and activity in hypo/mania and decreased mood, energy and activity in depression. 4 Most recently, the DSM-5 has revised the criteria for bipolar disorder, 5 stating that the A criterion for mania and hypomania should include 'a distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased activity or energy' (italics added). Also, DSM-5 allows a specified 'with mixed features' (a descriptor that can be added when a person experiences both symptoms of depression and mania within the same episode). Diverging from ICD-10, the DSM-5 does not elevate activity and energy to the A criterion for bipolar depression (i.e. major depressive episode in the context of bipolar disorder).
Activation as a core dimension of bipolar disorders
The changes in diagnostic criteria for bipolar disorder have received qualified support. For example, in our recent systematic review, 6 we conceptualised activity and energy, respectively, as the observable and subjective elements of activation in bipolar disorder and found that (a) activation was the most common primary dimension in mania and (b) there were differences in the factor structure of bipolar as compared with unipolar depression (for example psychomotor activity, suicidality and sleep) despite minimal differences in overall levels of symptom severity. Further, we demonstrated evidence of disturbed activation in bipolar disorder studies that employed real-time monitoring (for example experiential sampling methods and ecological momentary assessment) or objective measurements (for example actigraphy and human behaviour pattern monitoring). Although debate continues around current diagnostic descriptions, we concluded that the elevation of activation to an obligatory symptom of hypo/mania was evidence based.
Given that the concept of bipolar disorder has evolved over the last half-century, it is unclear how well the most widely used clinical scales capture contemporary diagnostic criteria, especially regarding activation (activity and/or energy). Many mania and depression rating scales were developed some 30-40 years ago and demonstrate considerable heterogeneity in the range of assessed symptoms and in underlying assumptions about the nature of bipolar disorder episodes. For example, the influential Young Mania Rating Scale (YMRS) 7 was introduced around the time the bipolar disorder construct replaced MDI in classification systems, and its items preclude rating an episode as dysphoric mania (i.e. depressed mood with increased activity and other symptoms of mania), one of the most common presentations (such as Goodwin & Jamison 8 ) or the formal assessment of the DSM-5 mixed features specifier.
Assessment of activation in symptom rating scales
Given the above, we undertook a preliminary scoping review to identify the archetypal measures of the symptom states of bipolar disorder and examined those scales with sound psychometrics. As a first step in assessing scales' concordance with contemporary diagnostic criteria, we calculated the weighting of activation items, quantified as the percentage of the maximum possible score (POMP). As a point of comparison, POMP scores were also calculated for mood-related items.
As expected, the most commonly used scales aim to measure one of the two major syndromes in a bipolar conceptualisation. The most widely used mania rating scale was the clinician-rated YMRS, 7 on which a single (increased) activation item has little impact on total score (activation POMP 7%; mood POMP 20%). Activation is weighted higher on the Bech Rafaelson Mania Scale (POMP 18%) 9 and the self-report Altman Self-Rating Scale (POMP 20%). 10 The most widely used depression rating scale was the 17-item clinician-rated Hamilton Rating Scale for Depression (HRSD).
11
The 17-item HRSD score (activation POMP 8%; mood: depression POMP 8% and anxiety POMP 8%) weighs activation less than does the 30-item Inventory of Depressive Symptoms (IDS clinician or self-rated versions: POMP 14%). 12 Also, the Montgomery-Åsberg Rating Scale (MADRS) 13 gives less priority to activation than to mood (activation POMP 10%, mood POMP 20%). Overall, the depression scale with the maximal weight for an activation dimension is the Quick IDS (QIDS or IDS-16: POMP 22%).
14 Activation is weighted even lower on common self-rating compared with observer-rated depression scales: depending on the version, the Beck Depression Inventory, for example, generated activation POMPs of about 4-9%. 15 Our review also identified scales not premised on the assumption that this complex condition is best characterised as two fundamental contrasting mood states. Newer scales like the self-rated MaTHyS (Multidimensional Assessment of Thymic States), 16 for example, quantify points in a theoretically derived multidimensional bipolar disorder state space (emotional reactivity, motivation, sensory-perception, psychomotor activity, cognition speed). The earlier self-reported Internal State Scale has the same logic, but measures four dimensions (activation, well-being, perceived conflict, depression index). 17 Such multidimensional scales capture more forms of dysregulation and uncouple mood and activation, but they are not yet widely used.
Discussion
Our preliminary review raises concerns about the content validity of the most widely used symptom rating scales, the YMRS, MADRS and the 17-item HRSD. The POMP estimates suggest that none of these scales weight activation in a manner proportionate to its cardinal symptom status in DSM-5 (hypo/mania) and ICD-10 (hypo/mania and depression). Our strategy here of calculating the weighting given to activation is more rhetorical than quantitative, and more rigorous investigation of this issue is now warranted: our group is currently undertaking a systematic review of the psychometric and clinimetric properties, and external correlates of the major scales.
Coincidentally, researchers have recently questioned whether some of the most established rating scales are fit for purpose on other grounds. For example, YMRS scores show non-significant correlations with objective measures of mania. 6 Also, an itemresponse theory analysis of the utility of the YMRS and MADRS concluded that both these scales are poorly constructed and inefficient (for example they contained several items that provided little or no psychometric information and only measured a narrow band of severity of symptoms) or that answers were, in part, determined by factors other than symptom severity. 18 Likewise, the utility of the HRSD has been increasingly questioned. 19 Questions about the proportionality of activation weighting (the focus here) may not be separate from other validity issues: for example the HRSD-6 (targeting six symptom dimensions) has the highest activation POMP score among versions of the HRSD (POMP 17%) and is superior to longer HRSD versions in terms of psychometric performance, item-response theory analysis and clinimetric profile. 20 
Conclusions and recommendations
Recent changes to the diagnostic criteria for bipolar disorder, underpinned by growing research into its dimensional nature, motivate critical attention to the rating scales with which diagnoses are supposed to be paired. This initial scoping review highlights that the so-called gold-standard tools for the assessment of manic and depressive episodes may be limited in the assessment of the evolving bipolar disorder construct as defined by DSM-5 and ICD-10.
There are obvious benefits in using well-benchmarked scales, so in the short-term researchers and clinicians should choose from existing scales, mindful of their match with the diagnostic syndrome they are hoping to ameliorate (for example preferencing mania scales that give more equal weighting to mood and activation and/or uncouple elation from increased activity, depression from retardation). In the longer term, we await rating scales built on improved understanding of the dimensional structure of bipolar disorder, and pragmatic guidance about how such complex measures will be used to monitor and manage the condition in real time.
